The 14th Asian Congress on Endometriosis
The 14th Asian Congress on Endometriosis (ACE 2026) will be held from 23–25 October 2026 at Pan Pacific Singapore, under the theme “Changing the Narrative: A New Dawn for Endometriosis and Adenomyosis.”
The congress brings together leading regional and international experts, clinicians, surgeons, researchers and allied health professionals to explore advances in the understanding, diagnosis and management of endometriosis and adenomyosis.
ACE 2026 features a comprehensive scientific programme covering translational research, precision diagnosis, advanced imaging, pain management, fertility and reproductive outcomes, complex and minimally invasive surgery, adenomyosis, adolescent disease and multidisciplinary patient-centred care.
Key sessions include deep infiltrating endometriosis, robotics and digital technology in surgery, experimental and translational research, reproductive outcomes, disease across the life course, emerging therapeutic targets and the management of adenomyosis.
Beyond scientific lectures, the congress offers hands-on workshops, networking opportunities, country and international society sessions, and opportunities to present original research through oral presentations, videos and digital posters. The meeting is designed to encourage collaboration and knowledge exchange while translating new evidence and innovations into better standards of care.
The congress venue, Pan Pacific Singapore in Marina Bay, provides a central and convenient setting for delegates, with recommended accommodation options and special delegate arrangements available.
With its strong international faculty, broad scientific scope and emphasis on innovation, collaboration and patient-centred care, ACE 2026 aims to help shape the future of endometriosis and adenomyosis management across Asia and beyond.
President of ACE Congress 2026
YF Fong
